| 2-AMINO-3,8-DIMETHYLIMIDAZO[4,5-F]QUINOXALINE |
2-氨基-3,8-二甲基咪唑并喹喔啉 |
77500-04-0 |
| EPICHOLESTEROL |
表膽甾醇 |
474-77-1 |
| PD318088 |
5-溴-N-(2,3-二羟基丙氧基)-3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯甲酰胺 |
391210-00-7 |
| BMS-1001 |
BMS-1001 |
2113650-03-4 |
| 2088365-27-7 |
2088365-27-7 |
2088365-27-7 |
| (S)-C33 |
(S)-C33 |
2066488-39-7 |
| AVN-944 |
化合物AVN944 |
297730-17-7 |
| CP-547632 |
3-[(4-溴-2,6-二氟苄基)氧基]-5-[3-[4-(吡咯烷-1-基)丁基]脲基]异噻唑-4-甲酰胺 |
252003-65-9 |
| N-[2-[[(3R)-1-[(4-chlorophenyl)methyl]-3-pyrrolidinyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamidehydrochloride |
226226-39-7 |
226226-39-7 |
| Benzo[b]thiophene-6-ol, 2-(4-hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenyl]- |
Benzo[b]thiophene-6-ol, 2-(4-hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenyl]- |
216570-81-9 |
| SBC110,736 |
1629166-02-4 |
1629166-02-4 |
| 4-Methyl-3-[[6-(methylamino)-4-pyrimidinyl]oxy]-N-[3-(4-methyl-1-piperazinyl)-5-(trifluoromethyl)phenyl]benzamide |
化合物 T26280 |
1620820-12-3 |
| (3S)-N-[3-Hydroxy-5-[(1,4,5,6-tetrahydro-5-hydroxy-2-pyriMidinyl)aMino] benzoyl]glycyl-3-(3-broMo-5-t-butylphenyl)-beta-alanine |
CWHM-12 |
1564286-55-0 |
| CEP-37440 |
CEP-37440 |
1391712-60-9 |
| Atezolizumab |
阿特珠单抗 |
1380723-44-3 |
| MK 5172 hydrate |
阿那匹韦 |
1350462-55-3 |
| 5-PyriMidinecarboxaMide, 4-[(2-Methylpropyl)aMino]-N-(phenylMethyl)-2-[4-[(tetrahydro-2H-pyran-3-yl)Methyl]-1-piperazinyl]- |
CS-2357 |
1332708-14-1 |
| MAK-683 |
CPD 1111 |
1951408-58-4 |
| PQR530 |
PQR530 |
1927857-61-1 |
| VRT-1353385 |
VRT-1353385 |
1616113-45-1 |
QQ
微信
